Penn Medicine Researchers Identify Biomarkers That May Predict Cognitive Impairment in New Parkinson's Disease Patients
New biomarkers identified by a research team in the Perelman School of Medicine at the University of Pennsylvania could help predict which Parkinson’s disease patients will suffer significant cognitive deficits within the first three years of their diagnosis. The results of the analysis from the international Parkinson’s Progression Markers Initiative (PPMI) are published this week in the open-access journal PLoS ONE.More Research
UDALL IN THE NEWS
06/30/17Could new biomarkers predict which Parkinson's disease patients are most likely to suffer early or severe cognitive decline?
05/18/17Parkinson's disease affects about half a million people in the United States. New research identifies biomarkers that could predict the cognitive impairment…
05/01/17About a million people in the United States have Parkinson’s disease, a neurological disorder that causes not only physical symptoms, like tremors, muffled…
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.